Sysmex Astrego is a diagnostics company based in Uppsala, Sweden, focused on supporting the global fight against antimicrobial resistance. Founded as Astrego Diagnostics in March 2017, the company was acquired by Japan’s Sysmex Corporation in May 2022. Its team brings together scientific expertise, entrepreneurial experience and diagnostic-industry management.

The company develops antibiotic susceptibility testing (AST) technology designed to deliver fast, sensitive and precise results through a fully automated system. The system is intended for use in both near-patient settings and central laboratories, helping healthcare professionals identify bacterial infections and determine which antibiotics may be effective. One application is testing for urinary tract infections at the point of care, with potential use in other areas involving bacterial infections.

Through its diagnostic products, Sysmex Astrego aims to provide timely information that can support clinical decision-making and more targeted antibiotic use. The company is part of the wider Sysmex Group and shares information about its technology, products, company activities and events through its website.